Skip to content
healthcare.dev

Depo-SubQ Provera

NDC 0009-4709, medroxyprogesterone acetate, injection, suspension, from Pharmacia & Upjohn Company LLC.

Product NDC
0009-4709
Status
Listed
Labeler
Pharmacia & Upjohn Company LLC
Dosage form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021583
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0009-4709 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MEDROXYPROGESTERONE ACETATE104 mg/.65mL

Pharmacologic classes

Progesterone Congeners [CS]; Progestin [EPC]

Package NDCNDC-11Package
0009-4709-13000094709131 SYRINGE in 1 CARTON (0009-4709-13) / .65 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/390087a6-f3c3-4f0b-a930-79acf412f153
  • NADAC price for package 00009470913

    GET /v1/drugs/nadac/00009470913

Use it

Look up 0009-4709 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0009-4709 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0009-4709. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.